Radiofrequency ablation of XXXX .

@entity1 @entity5 @entity1009 @entity177 @entity1358 @entity703
OBJECTIVES: The treatment of @entity1358 is challenging. Radiofrequency ablation has been increasingly applied in the management of @entity703 . Herein, we report our experience of radiofrequency ablation on 12 @entity1 with @entity1358 . METHODS: From March 2006 to September 2010, 12 @entity1 with bilateral @entity1358 (29 lesions overall) were identified from our kidney database. The mean age was 62.3 years (range 35-81). The mean @entity5 diameter was 4.5 cm (range 0.9-9.0). Three @entity1 received unilateral radiofrequency ablation and contralateral radical nephrectomy, whereas nine @entity1 received bilateral radiofrequency ablation. The oncological and functional outcomes were analyzed. Contrast-enhanced computed tomography examinations were carried out at day 7, and at 3 and 6 months after the procedure, and every 6 months thereafter. RESULTS: The mean follow-up period was 33 months (range 10-64). The @entity5 control rate was 93.1% (27/29). Cancer-specific survival and the overall survival rates were 100%. No death or @entity177 after the procedure was found. In @entity1 who underwent bilateral radiofrequency ablation, the latest mean glomerular filtration rate had not significantly declined compared with preoperative levels (93.7    13.0 mL/ @entity1009 .73 m(2) vs 96.9    13.3 mL/ @entity1009 .73 m(2), respectively; P > 0.05). CONCLUSION: Radiofrequency ablation shows encouraging outcomes in the treatment of @entity1358 . It can provide adequate @entity5 control and @entity5 -specific survival compared with nephron-sparing surgery while not affecting the renal function.
